Fed. Cir.

Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc., No. 24-1021 (Fed. Cir. Nov. 6, 2024)

General / Procedural

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 24-1021
Decided: November 6, 2024
Judge: See opinion
Document: Nonprecedential Opinion
Length: 2 pages

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit FATE THERAPEUTICS, INC., WHITEHEAD

INSTITUTE FOR BIOMEDICAL RESEARCH,

Plaintiffs-Appellants

SHORELINE BIOSCIENCES, INC.,

Defendant-Cross-Appellant

2024-1021, 24-1055

Appeal from the United States District Court for the Southern District of California in No. 3:22-cv-00676-H-MSB, Senior Judge Marilyn L. Huff.

O R D E R

The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App.

P. 42 (b).

22 FATE THERAPEUTICS, INC. V. SHORELINE BIOSCIENCES, INC.

(2) Each side shall bear their own costs.

FOR THE COURT

November 6, 2024

Date

ISSUED AS A MANDATE: November 6, 2024

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc., No. 24-1021 (Fed. Cir. Nov. 6, 2024).

Record ID: CAFC-24-1021-20241106
Permalink: https://patentcasewatch.com/opinions/CAFC-24-1021-20241106

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error